MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Objective Measurement in Routine Care of People with Parkinson’s Disease Improves Outcomes

    M. Horne, P. Farzanehfar, H. Woodrow, M. Braybrook, S. McGregor, A. Evans, F. Nicklason (Parkville, Australia)

    Objective: This pilot study was designed to use Objective Measurement (OM) of symptoms of Parkinson’s Disease (PD) to identifying the proportion of people with PD…
  • 2018 International Congress

    Hemiballismus as single manifestation of nonketotic hyperglycemia in elderly

    N. Raisa, K. Jusbandi (Malang, Indonesia)

    Objective: To describe an elderly patient with the rare manifestation of hyperglycemia in new onset diabetes mellitus. Background: The most common cause of new-onset hemibody…
  • 2018 International Congress

    Evaluating the impact of the educational course for nurses on Parkinson’s disease: A model for continuing nursing education

    S. Phumphid, O. Jitkritsadakul, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To evaluate the level of general PD knowledge among the nursing community and to determine the impact of a PD educational program on their…
  • 2018 International Congress

    Determinants of Bed Mobility Proficiency in Patients with Parkinson’s Disease: A Pilot Study

    S. Taniguchi, N. D’Cruz, T. Osaki, M. Nakagoshi, A. Nieuwboer, T. Shimokawa (Kobe, Japan)

    Objective: To investigate the motor and cognitive factors contributing to time to get out of bed in patients with Parkinson’s Disease (PD). Background: The majority…
  • 2018 International Congress

    The Quality of life in Parkinson’s disease. A follow-up study among 621 Finnish people with Parkinson

    K. Martikainen, S. Kinos, T. Vahlberg, R. Marttila (Turku, Finland)

    Objective: To find the most significant factors on the quality of life and its changes in a large sample of people with Parkinson. Background: The…
  • 2018 International Congress

    Caregiver Burden in a Multidisciplinary MSA Clinic

    M. Salinas, E. Kent, S. Vernino, P. Khemani (Dallas, TX, USA)

    Objective: To explore the correlation between disease and caregiver burden in MSA. Background: For patients with Multiple System Atrophy (MSA), the increasing loss of independence…
  • 2018 International Congress

    Prevalence and predictors of mood and health-related quality of life impairment among patients with parkinson’s in sub-saharan neurology clinic

    U. Williams, S. Oparah, H. Okpa (Calabar, Nigeria)

    Objective: This study was design to determine patient’s self-assessed health quality of life measures and mood. We also aimed at establishing the relationship between the…
  • 2018 International Congress

    Annual Clinical Evaluation in Out Patient Clinic May Improve Quality of Life in Patients with Parkinson’s Disease

    M. Tomiyama, T. Ueno (Aomori, Japan)

    Objective: The aim of this study was to examine whether the annual clinical evaluation system improves QOL in Parkinson’s disease (PD) patients. Background: We perform…
  • 2018 International Congress

    Neurohormetic properties of mild physical stress against Parkinson’s disease phenotype

    S. Kumari K.N (Zunheboto, India)

    Objective: To test whether routine mild physical stress acts as a hormetic strategy against Parkinsonian symptoms among mice. Background: Regular physical exercise is suggested to…
  • 2018 International Congress

    Quality of Life and Psychiatric Comorbidities Comparisons in Patients with Functional (Psychogenic) and Organic Movement Disorders

    T. Gendre, G. Carle, F. Mesrati, M. Houot, B. Degos, B. Garcin (Créteil, France)

    Objective: To compare the quality of life (QoL) and psychiatric comorbidities of patients with functional (psychogenic) movement disorders (FMD) and patients with organic movements disorders…
  • « Previous Page
  • 1
  • …
  • 1295
  • 1296
  • 1297
  • 1298
  • 1299
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley